Delivery Order SPE2DB20D3104-SPE2DB25FV7E9

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,394 units of Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The fixed-price contract has a ceiling value of $3,093.30 and a period of performance through March 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,724,135 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $13,755.29 and a completion date of December 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,953,486 units of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $12,081.79 and an ultimate completion date of May 17, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $4,943.11 and a performance period through May 8, 2025. It is a Firm Fixed Price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,790,375 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The fixed-price contract has a ceiling value of $9,401.38 and a completion date of December 24, 2024. AmerisourceBergen, a for-profit organization, is registered in the System for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,469,416 units of the prescription drug Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $1,735.60 and a period of performance through August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $13,937.41 and a completion date of February 20, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a Ceiling Value of $5,700.40 and an Ultimate Completion Date of February 3, 2025. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,756,330 units of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $8,048.13 and a completion date of February 26, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,114,688 units of the prescription medication Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $13,585.32 and a performance period extending through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA Troop Support Medical,...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV7E9
    Delivery Order

This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,568,198,078 units of the medication Ondansetron ODT 4 mg tablet, which is used to treat nausea and vomiting. The contract has a ceiling value of $13,255.49 and a period of performance through May 12, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/8/25, 10:10 AM